• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: DEPUY IRELAND - 9616671 UNK SHOULDER HUMERAL EPIPHYSIS DELTA XTEND

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

DEPUY IRELAND - 9616671 UNK SHOULDER HUMERAL EPIPHYSIS DELTA XTEND Back to Search Results
Catalog Number UNK SHOULDER HUMERAL EPIPHYSIS
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Pulmonary Embolism (1498); Anemia (1706); Nerve Damage (1979); Loss of Range of Motion (2032); Joint Laxity (4526); Appropriate Clinical Signs, Symptoms, Conditions Term / Code Not Available (4581)
Event Date 01/01/2019
Event Type  Injury  
Manufacturer Narrative
(b)(4).If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
 
Event Description
Article entitled ¿complications after surgical treatment of proximal humerus fractures in the elderlydan analysis of complication patterns and risk factors for reverse shoulder arthroplasty and angular-stable plating" written by alexander klug, md, dennis wincheringer, md, jasmin harth, ms, kay schmidt-horlohe, md, reinhard hoffmann, md, yves gramlich, md, published by the journal of shoulder and elbow surgery 2019 was reviewed.The current study was designed to evaluate which surgical procedure (angular-stable plating or rtsa) leads to lower complication and revision rates, and to determine possible independent risk factors in an elderly population.Between 2012 and 2017, 146 patients (aged 74.1 8.0 years) with complex phf were treated with locking plates (open reduction-internal fixation [orif]) or reverse total shoulder arthroplasty (rtsa).Complications and unplanned revision surgery were recorded in a mid-term follow-up.Potential patient and surgical risk factors for complications were extracted.Univariate and multivariate analyses were conducted.Follow-up data were available for 125 patients, 66 (52.8%) of whom were treated with locking plates, and 59 (41.2%) with rtsa.The overall complication rate was 37.8% for orif and 22.0% for rtsa, with a revision rate of 12.1% and 5.1%, respectively, as driven primarily by persistent motion deficits.Multivariate analyses demonstrated no significant differences between the 2.However, age was an independent protective factor against overall complications.Risk factors for major complications in orif included osteoporosis, varus impaction fractures, posteromedial metaphyseal extensions 4 mm, and multifragmentary greater tuberosities.For rtsa, higher complication rates were seen in patients with higher charlson indices, diabetes, or altered (greater) tuberosities.In contrast, neer¿s classification system was not predictive in either group.Depuy products: reverse shoulder prosthesis (delta xtend).Adverse events: motion deficits 9, instability 3, axillary nerve lesion 2, scapular notching 7, radiolucent lines (stem) 2, pulmonary embolism 2, postoperative anemia 1.
 
Manufacturer Narrative
Product complaint # (b)(4).Investigation summary: no device associated with this report was received for examination.All available x-rays were reviewed, and no evidence of implant fracture, disassociation, or anything indicative of a device nonconformance was found.Depuy synthese considers the investigation closed at this time.Should additional information be received, the information will be reviewed, and the investigation may be re-opened as necessary.  device history lot : a device history record (dhr) review or manufacturing records evaluation (mre) was not possible because the required lot code was not provided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
UNK SHOULDER HUMERAL EPIPHYSIS DELTA XTEND
Type of Device
SHOULDER HUMERAL EPIPHYSIS
Manufacturer (Section D)
DEPUY IRELAND - 9616671
loughbeg ringaskiddy co.
cork
EI 
Manufacturer (Section G)
DEPUY ORTHOPAEDICS, INC. 1818910
700 orthopaedic dr.
warsaw IN 46581 0988
Manufacturer Contact
kara ditty-bovard
700 orthopaedic dr.
warsaw, IN 46581-0988
6107428552
MDR Report Key12488502
MDR Text Key271925166
Report Number1818910-2021-20406
Device Sequence Number1
Product Code PHX
Combination Product (y/n)N
Reporter Country CodeGM
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Literature,Health Professional
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 08/27/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/17/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberUNK SHOULDER HUMERAL EPIPHYSIS
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received11/19/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-